Información del producto
MKC 9989 is a small molecule that is designed to target cancer cells. It has been shown to cause cell dysfunction by binding to lysine residues on the surface of cancer cells and removing proton from the cell, which impairs its ability to function. MKC 9989 also binds to hydrogen bonds on the surface of cancer cells and prevents them from forming imines, which are important for cellular metabolism. This drug has been shown to be effective in treating cancers in animal models and may be used as an alternative treatment option for patients who have not responded well to other therapies such as chemotherapy or radiation therapy.
Propiedades químicas
Consulta técnica sobre: 3D-NDC93420 MKC9989
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
